Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $9.01 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 45.20.
Market Cap
9.01T
Revenue
4.59T
Profits
199.3B
PE Ratio
45.20
Profit Margin
4.34%
Dividend Yield
0.39%
1056 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.10T | 1.81% | 3,684,716 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 622.29B | 1.51% | 8,608,146 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 449.31B | 0.38% | 9,826,516 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 381.26B | -1.89% | 5,167,402 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 319.55B | 0.56% | 9,584,591 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 293.79B | 1.35% | 1,644,461 | 60.44B |
| 7 | NVS | Novartis AG | 285.79B | 1.40% | 2,315,097 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 213.15B | 0.56% | 9,322,893 | 50.57B |
| 9 | AMGN | Amgen Inc. | 194.59B | 0.62% | 2,461,889 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 188.20B | -1.29% | 2,076,446 | 45.20B |
| 11 | ABT | Abbott Laboratories | 161.48B | -1.50% | 10,422,041 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 156.85B | -1.21% | 6,815,501 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 143.78B | 0.31% | 2,328,654 | 10.58B |
| 14 | PFE | Pfizer Inc. | 138.90B | 0.33% | 47,527,952 | 63.32B |
| 15 | DHR | Danaher Corporation | 136.44B | -1.74% | 3,522,471 | 24.78B |
| 16 | CVS | CVS Health Corporation | 132.16B | -0.73% | 4,788,022 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 126.81B | 1.69% | 2,017,940 | 12.22B |
| 18 | SYK | Stryker Corporation | 126.71B | -0.66% | 2,810,020 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 119.58B | 1.81% | 11,770,857 | 48.48B |
| 20 | GSK | GSK plc | 104.50B | 0.59% | 4,183,247 | 43.29B |
| 21 | MDT | Medtronic plc | 103.59B | -0.06% | 8,597,174 | 36.36B |
| 22 | SNY | Sanofi | 103.49B | 1.12% | 2,809,535 | 54.60B |
| 23 | MCK | McKesson Corporation | 87.52B | -2.09% | 1,559,886 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 87.03B | 0.17% | 1,225,133 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 84.27B | -1.81% | 1,222,748 | 200.42B |
| 26 | CI | The Cigna Group | 73.74B | -1.43% | 1,370,940 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 64.63B | -1.70% | 21,895,443 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 64.28B | -0.17% | 732,421 | 14.92B |
| 29 | ARGX | argenx SE | 55.78B | 2.85% | 272,413 | 4.74B |
| 30 | CAH | Cardinal Health, Inc. | 55.32B | -0.71% | 1,926,610 | 250.74B |
| 31 | COR | Cencora, Inc. | 54.80B | -1.57% | 1,009,699 | 328.68B |
| 32 | EW | Edwards Lifesciences Corporation | 52.50B | 0.44% | 3,606,378 | 6.30B |
| 33 | MDLN | Medline Inc. | 52.04B | 1.90% | 8,383,948 | 29.14B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 50.50B | 0.44% | 3,657,874 | 28.34B |
| 35 | HUM | Humana Inc. | 46.69B | 1.32% | 1,231,100 | 137.20B |
| 36 | BDX | Becton, Dickinson and Company | 42.76B | -0.47% | 2,396,587 | 22.23B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 42.28B | -2.82% | 799,312 | 4.45B |
| 38 | RVMD | Revolution Medicines, Inc. | 40.95B | 5.79% | 5,312,641 | - |
| 39 | HLN | Haleon plc | 40.69B | 0.97% | 9,131,506 | 14.85B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.19B | 0.74% | 1,367,299 | 4.29B |
| 41 | NTRA | Natera, Inc. | 39.00B | 3.97% | 1,783,757 | 2.50B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 38.79B | 0.30% | 3,271,625 | 17.35B |
| 43 | A | Agilent Technologies, Inc. | 37.52B | -2.34% | 1,987,812 | 7.23B |
| 44 | WAT | Waters Corporation | 36.22B | -1.48% | 981,212 | 3.77B |
| 45 | ALC | Alcon Inc. | 32.91B | -0.28% | 1,857,768 | 10.63B |
| 46 | RPRX | Royalty Pharma plc | 32.87B | 1.53% | 2,480,456 | 2.44B |
| 47 | IQV | IQVIA Holdings Inc. | 32.26B | 1.12% | 1,291,800 | 16.63B |
| 48 | ONC | BeOne Medicines AG | 32.24B | 3.61% | 317,521 | 5.70B |
| 49 | BIIB | Biogen Inc. | 31.98B | 0.28% | 1,255,842 | 9.94B |
| 50 | CNC | Centene Corporation | 31.87B | -1.81% | 5,920,877 | 178.33B |
| 51 | ZTS | Zoetis Inc. | 30.71B | -3.73% | 6,528,785 | 9.53B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 29.59B | -1.08% | 4,010,809 | 20.98B |
| 53 | RMD | ResMed Inc. | 28.66B | -0.93% | 1,396,294 | 5.54B |
| 54 | VEEV | Veeva Systems Inc. | 28.63B | 2.84% | 3,299,620 | 3.32B |
| 55 | MRNA | Moderna, Inc. | 27.66B | 3.61% | 8,077,382 | 2.23B |
| 56 | ILMN | Illumina, Inc. | 27.40B | 2.58% | 1,507,861 | 4.39B |
| 57 | DXCM | DexCom, Inc. | 27.00B | -0.23% | 3,978,625 | 4.82B |
| 58 | PHG | Koninklijke Philips N.V. | 25.91B | 0.41% | 828,886 | 20.34B |
| 59 | MTD | Mettler-Toledo International Inc. | 25.44B | -0.39% | 243,639 | 4.09B |
| 60 | WST | West Pharmaceutical Services, Inc. | 25.06B | 1.09% | 695,751 | 3.22B |
| 61 | ROIV | Roivant Sciences Ltd. | 24.98B | 1.94% | 6,384,419 | 8.26M |
| 62 | BNTX | BioNTech SE | 23.84B | 3.33% | 935,862 | 3.23B |
| 63 | DGX | Quest Diagnostics Incorporated | 23.54B | 1.32% | 786,334 | 11.28B |
| 64 | UTHR | United Therapeutics Corporation | 23.13B | 0.42% | 420,254 | 3.17B |
| 65 | LH | Labcorp Holdings Inc. | 22.93B | 2.99% | 869,833 | 14.14B |
| 66 | INCY | Incyte Corporation | 22.91B | 0.80% | 1,532,380 | 5.36B |
| 67 | INSM | Insmed Incorporated | 22.70B | 1.32% | 2,747,518 | 819.56M |
| 68 | STE | STERIS plc | 20.78B | -1.13% | 897,888 | 5.94B |
| 69 | GH | Guardant Health, Inc. | 20.39B | 3.03% | 2,730,608 | 1.08B |
| 70 | VTRS | Viatris Inc. | 18.90B | -0.61% | 8,986,925 | 14.56B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.65B | -2.00% | 1,908,041 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 17.09B | 0.88% | 1,346,040 | 3.10B |
| 73 | ASND | Ascendis Pharma A/S | 16.38B | 1.13% | 901,594 | 998.25M |
| 74 | GMAB | Genmab A/S | 16.12B | -0.38% | 2,029,457 | 3.90B |
| 75 | THC | Tenet Healthcare Corporation | 16.12B | -0.97% | 1,118,973 | 21.46B |
| 76 | MEDP | Medpace Holdings, Inc. | 15.27B | 1.45% | 390,789 | 2.68B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 14.92B | 3.35% | 975,090 | 4.44B |
| 78 | BTSG | BrightSpring Health Services, Inc. | 14.37B | - | 3,977,541 | 13.65B |
| 79 | DVA | DaVita Inc. | 14.10B | 1.23% | 836,997 | 13.84B |
| 80 | BBIO | BridgeBio Pharma, Inc. | 14.10B | 2.52% | 3,263,915 | 579.96M |
| 81 | COO | The Cooper Companies, Inc. | 13.92B | 0.52% | 2,783,568 | 4.23B |
| 82 | EXEL | Exelixis, Inc. | 13.64B | -0.89% | 2,587,319 | 2.38B |
| 83 | SOLV | Solventum Corporation | 13.55B | -1.62% | 1,076,372 | 8.26B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 13.34B | -0.60% | 2,806,517 | 1.06B |
| 85 | ICLR | ICON Public Limited Company | 13.25B | 1.84% | 1,359,733 | 8.27B |
| 86 | SNN | Smith & Nephew plc | 12.85B | 0.80% | 1,046,449 | 6.16B |
| 87 | ALGN | Align Technology, Inc. | 12.42B | -2.80% | 973,262 | 4.10B |
| 88 | AXSM | Axsome Therapeutics, Inc. | 12.41B | -0.23% | 1,355,396 | 708.24M |
| 89 | PEN | Penumbra, Inc. | 12.41B | -0.37% | 330,774 | 1.45B |
| 90 | RVTY | Revvity, Inc. | 12.41B | -1.60% | 2,018,101 | 2.90B |
| 91 | ELAN | Elanco Animal Health Incorporated | 12.36B | 0.69% | 3,310,971 | 4.89B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.16B | 2.85% | 446,019 | 1.13B |
| 93 | FMS | Fresenius Medical Care AG | 12.13B | -2.32% | 863,829 | 22.32B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 12.12B | -3.38% | 5,316,955 | 3.58B |
| 95 | MOH | Molina Healthcare, Inc. | 11.96B | -0.09% | 1,128,723 | 43.10B |
| 96 | CYTK | Cytokinetics, Incorporated | 11.85B | 6.17% | 3,596,088 | 105.82M |
| 97 | GMED | Globus Medical, Inc. | 11.39B | -2.68% | 1,644,338 | 3.10B |
| 98 | BAX | Baxter International Inc. | 11.37B | -0.09% | 5,722,298 | 11.32B |
| 99 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.34B | 2.04% | 1,649,377 | 622.01M |
| 100 | KRYS | Krystal Biotech, Inc. | 11.15B | 1.58% | 287,453 | 417.30M |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 11.15B | -2.25% | 1,793,509 | 3.24B |
| 102 | SMMT | Summit Therapeutics Inc. | 11.11B | 2.21% | 5,977,787 | - |
| 103 | TECH | Bio-Techne Corporation | 11.05B | -0.14% | 14,728,008 | 1.21B |
| 104 | PODD | Insulet Corporation | 10.93B | -0.32% | 1,561,425 | 2.90B |
| 105 | CRL | Charles River Laboratories International, Inc. | 10.87B | 4.55% | 1,091,781 | 4.03B |
| 106 | TEM | Tempus AI, Inc. | 10.47B | 3.87% | 8,184,587 | 1.36B |
| 107 | EHC | Encompass Health Corporation | 10.01B | -0.42% | 906,389 | 6.07B |
| 108 | APGE | Apogee Therapeutics, Inc. | 9.94B | 0.05% | 3,094,224 | - |
| 109 | PRAX | Praxis Precision Medicines, Inc. | 9.77B | 6.95% | 745,029 | 7.46M |
| 110 | NUVL | Nuvalent, Inc. | 9.76B | -0.01% | 1,263,190 | - |
| 111 | HSIC | Henry Schein, Inc. | 9.60B | -0.71% | 1,104,726 | 13.38B |
| 112 | CORT | Corcept Therapeutics Incorporated | 9.44B | 0.65% | 864,937 | 769.10M |
| 113 | IBRX | ImmunityBio, Inc. | 9.19B | 0.69% | 15,768,466 | 140.98M |
| 114 | ENSG | The Ensign Group, Inc. | 9.17B | -2.98% | 833,271 | 5.27B |
| 115 | HALO | Halozyme Therapeutics, Inc. | 9.15B | 2.96% | 2,245,438 | 1.51B |
| 116 | BRKR | Bruker Corporation | 9.09B | -1.97% | 2,038,956 | 3.46B |
| 117 | KYMR | Kymera Therapeutics, Inc. | 8.99B | 1.11% | 1,675,461 | 51.48M |
| 118 | UHS | Universal Health Services, Inc. | 8.90B | 0.91% | 1,064,183 | 17.76B |
| 119 | OSCR | Oscar Health, Inc. | 8.87B | -1.14% | 5,803,337 | 13.30B |
| 120 | ALKS | Alkermes plc | 8.76B | -4.63% | 2,938,429 | 1.56B |
| 121 | GKOS | Glaukos Corporation | 8.35B | -1.54% | 1,244,186 | 551.35M |
| 122 | PCVX | Vaxcyte, Inc. | 8.33B | 2.12% | 2,749,993 | - |
| 123 | QGEN | Qiagen N.V. | 8.23B | 0.96% | 2,317,309 | 2.10B |
| 124 | ATR | AptarGroup, Inc. | 8.00B | -0.55% | 446,637 | 3.87B |
| 125 | IMVT | Immunovant, Inc. | 7.91B | -0.88% | 1,329,832 | - |
| 126 | BIO | Bio-Rad Laboratories, Inc. | 7.90B | -1.83% | 329,316 | 2.59B |
| 127 | TGTX | TG Therapeutics, Inc. | 7.90B | -0.20% | 2,142,158 | 700.35M |
| 128 | SYRE | Spyre Therapeutics, Inc. | 7.83B | 2.58% | 1,993,934 | - |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 7.82B | -0.21% | 739,874 | 74.06M |
| 130 | HIMS | Hims & Hers Health, Inc. | 7.73B | -1.62% | 14,063,828 | 2.37B |
| 131 | RGEN | Repligen Corporation | 7.73B | -6.81% | 1,801,536 | 763.34M |
| 132 | ABVX | ABIVAX Société Anonyme | 7.58B | -1.38% | 2,771,894 | 5.67M |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.54B | 0.18% | 828,036 | 217.17M |
| 134 | MIRM | Mirum Pharmaceuticals, Inc. | 7.50B | -0.62% | 964,241 | 569.61M |
| 135 | HQY | HealthEquity, Inc. | 7.34B | -0.73% | 964,743 | 1.34B |
| 136 | LNTH | Lantheus Holdings, Inc. | 7.13B | -0.20% | 1,345,961 | 1.55B |
| 137 | AVTR | Avantor, Inc. | 6.85B | -2.43% | 8,632,168 | 6.55B |
| 138 | PTCT | PTC Therapeutics, Inc. | 6.77B | -3.39% | 4,327,766 | 827.11M |
| 139 | LQDA | Liquidia Corporation | 6.68B | -3.90% | 2,555,896 | 288.07M |
| 140 | COGT | Cogent Biosciences, Inc. | 6.62B | 1.68% | 3,215,995 | - |
| 141 | SRRK | Scholar Rock Holding Corporation | 6.59B | 0.37% | 2,095,148 | - |
| 142 | CGON | CG Oncology, Inc. | 6.50B | 2.46% | 1,094,031 | 5.07M |
| 143 | PACS | PACS Group, Inc. | 6.32B | -4.66% | 940,818 | 5.43B |
| 144 | HNGE | Hinge Health, Inc. | 6.30B | 3.18% | 4,342,086 | 646.34M |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.29B | 3.44% | 539,299 | 274.48M |
| 146 | GRFS | Grifols, S.A. | 6.27B | -0.81% | 518,871 | 8.58B |
| 147 | DFTX | Definium Therapeutics, Inc. | 6.18B | 3.56% | 4,674,752 | - |
| 148 | TWST | Twist Bioscience Corporation | 6.13B | -1.48% | 1,659,000 | 409.48M |
| 149 | BLTE | Belite Bio, Inc | 6.08B | 3.98% | 195,298 | - |
| 150 | CHE | Chemed Corporation | 6.08B | -0.73% | 117,085 | 2.54B |
| 151 | BLCO | Bausch + Lomb Corporation | 5.93B | 1.90% | 306,971 | 5.21B |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 5.81B | 0.65% | 1,688,682 | 7.50M |
| 153 | ERAS | Erasca, Inc. | 5.69B | 14.24% | 7,991,550 | - |
| 154 | LEGN | Legend Biotech Corporation | 5.69B | 2.44% | 1,289,143 | 1.14B |
| 155 | TFX | Teleflex Incorporated | 5.64B | -1.83% | 398,964 | 2.13B |
| 156 | ORKA | Oruka Therapeutics, Inc. | 5.58B | 2.09% | 1,734,799 | - |
| 157 | BLLN | BillionToOne, Inc. | 5.54B | 1.89% | 601,367 | 354.54M |
| 158 | AMRX | Amneal Pharmaceuticals, Inc. | 5.52B | 0.35% | 2,514,734 | 3.05B |
| 159 | CRSP | CRISPR Therapeutics AG | 5.43B | 2.60% | 1,844,482 | 4.10M |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.42B | -0.93% | 1,369,909 | 536.20M |
| 161 | DNTH | Dianthus Therapeutics, Inc. | 5.23B | 0.35% | 1,349,909 | 1.34M |
| 162 | CAI | Caris Life Sciences, Inc. | 5.18B | -0.97% | 3,779,616 | 907.29M |
| 163 | MANE | Veradermics, Incorporated | 5.16B | -2.61% | 722,274 | - |
| 164 | INDV | Indivior Pharmaceuticals, Inc. | 5.03B | -1.36% | 2,575,611 | 1.29B |
| 165 | CELC | Celcuity Inc. | 5.00B | 2.57% | 974,820 | - |
| 166 | SHC | Sotera Health Company | 5.00B | 0.81% | 2,378,162 | 1.19B |
| 167 | ALHC | Alignment Healthcare, Inc. | 4.81B | 0.30% | 6,622,790 | 4.26B |
| 168 | VCYT | Veracyte, Inc. | 4.80B | -0.50% | 1,485,877 | 541.74M |
| 169 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.80B | 5.42% | 1,531,531 | 754.05M |
| 170 | STVN | Stevanato Group S.p.A. | 4.74B | -2.69% | 254,519 | 1.39B |
| 171 | TXG | 10x Genomics, Inc. | 4.72B | 1.09% | 2,752,959 | 638.78M |
| 172 | TNGX | Tango Therapeutics, Inc. | 4.71B | 3.46% | 5,860,860 | 56.99M |
| 173 | RDNT | RadNet, Inc. | 4.66B | -2.40% | 812,981 | 2.14B |
| 174 | VKTX | Viking Therapeutics, Inc. | 4.59B | 3.94% | 2,888,595 | - |
| 175 | LIVN | LivaNova PLC | 4.56B | -0.44% | 1,050,345 | 1.43B |
| 176 | EWTX | Edgewise Therapeutics, Inc. | 4.40B | -1.30% | 1,932,525 | - |
| 177 | NVST | Envista Holdings Corporation | 4.40B | 0.22% | 2,516,336 | 2.81B |
| 178 | ACAD | ACADIA Pharmaceuticals Inc. | 4.32B | -0.47% | 2,089,208 | 1.10B |
| 179 | RLAY | Relay Therapeutics, Inc. | 4.30B | 6.36% | 4,215,703 | 10.68M |
| 180 | MMSI | Merit Medical Systems, Inc. | 4.18B | -2.29% | 836,313 | 1.54B |
| 181 | MMED | MiniMed Group, Inc. | 4.18B | 4.49% | 1,339,506 | 3.10B |
| 182 | DNLI | Denali Therapeutics Inc. | 4.11B | 1.25% | 2,175,463 | - |
| 183 | LFST | LifeStance Health Group, Inc. | 4.01B | 0.58% | 4,776,434 | 1.49B |
| 184 | NAMS | NewAmsterdam Pharma Company N.V. | 3.96B | 1.90% | 1,293,516 | 22.57M |
| 185 | RCUS | Arcus Biosciences, Inc. | 3.91B | 0.26% | 1,565,332 | 236.00M |
| 186 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.89B | 0.65% | 882,873 | 18.07M |
| 187 | IRTC | iRhythm Holdings, Inc. | 3.89B | -0.40% | 528,342 | 787.85M |
| 188 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | -0.13% | 1,752,832 | 596.96M |
| 189 | WAY | Waystar Holding Corp. | 3.83B | 0.40% | 1,812,831 | 1.16B |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 3.81B | -1.36% | 1,001,092 | 2.23B |
| 191 | BKD | Brookdale Senior Living Inc. | 3.79B | 0.95% | 4,993,377 | 3.00B |
| 192 | TLX | Telix Pharmaceuticals Limited | 3.78B | 6.00% | 302,153 | 803.79M |
| 193 | DOCS | Doximity, Inc. | 3.77B | -1.39% | 5,530,148 | 644.86M |
| 194 | PBLS | Parabilis Medicines, Inc. | 3.72B | 1.35% | 557,203 | - |
| 195 | ICUI | ICU Medical, Inc. | 3.70B | -0.23% | 344,137 | 2.16B |
| 196 | WRBY | Warby Parker Inc. | 3.69B | 2.98% | 2,867,361 | 890.57M |
| 197 | GPCR | Structure Therapeutics Inc. | 3.67B | 3.98% | 778,558 | - |
| 198 | OGN | Organon & Co. | 3.56B | 0.37% | 1,449,713 | 6.16B |
| 199 | ELVN | Enliven Therapeutics, Inc. | 3.55B | 1.54% | 1,572,485 | - |
| 200 | DYN | Dyne Therapeutics, Inc. | 3.51B | 1.53% | 2,171,732 | - |
| 201 | BEAM | Beam Therapeutics Inc. | 3.48B | 0.40% | 2,894,191 | 164.01M |
| 202 | IDYA | IDEAYA Biosciences, Inc. | 3.48B | -0.52% | 1,040,169 | 225.27M |
| 203 | ALMS | Alumis Inc. | 3.46B | 2.80% | 1,700,164 | 8.40M |
| 204 | ADPT | Adaptive Biotechnologies Corporation | 3.42B | 2.10% | 3,524,433 | 295.41M |
| 205 | HAE | Haemonetics Corporation | 3.41B | -2.81% | 612,908 | 1.33B |
| 206 | OPCH | Option Care Health, Inc. | 3.35B | -2.29% | 2,601,222 | 5.67B |
| 207 | ARQT | Arcutis Biotherapeutics, Inc. | 3.35B | -0.89% | 1,386,238 | 415.62M |
| 208 | QURE | uniQure N.V. | 3.26B | -0.25% | 2,303,988 | 18.09M |
| 209 | NHC | National HealthCare Corporation | 3.22B | -0.10% | 137,251 | 1.53B |
| 210 | PRVA | Privia Health Group, Inc. | 3.22B | -0.08% | 1,365,585 | 2.25B |
| 211 | VERA | Vera Therapeutics, Inc. | 3.10B | 1.63% | 3,394,248 | - |
| 212 | ITGR | Integer Holdings Corporation | 3.10B | -2.84% | 720,353 | 1.86B |
| 213 | RGC | Regencell Bioscience Holdings Limited | 3.07B | -4.48% | 400,024 | - |
| 214 | RARE | Ultragenyx Pharmaceutical Inc. | 3.01B | -0.29% | 3,995,157 | 670.00M |
| 215 | HTFL | HeartFlow, Inc. | 3.01B | -2.24% | 1,700,247 | 191.42M |
| 216 | CLDX | Celldex Therapeutics, Inc. | 2.94B | 6.18% | 1,579,136 | 865.00K |
| 217 | GRAL | GRAIL, Inc. | 2.94B | 3.75% | 482,762 | 156.12M |
| 218 | SLS | SELLAS Life Sciences Group, Inc. | 2.87B | 24.70% | 33,139,323 | - |
| 219 | IRON | Disc Medicine, Inc. | 2.85B | -0.37% | 1,454,441 | - |
| 220 | KLRA | Kailera Therapeutics, Inc. | 2.81B | 4.18% | 579,058 | - |
| 221 | CLOV | Clover Health Investments, Corp. | 2.80B | -1.85% | 8,461,830 | 2.21B |
| 222 | SUPN | Supernus Pharmaceuticals, Inc. | 2.72B | -0.09% | 941,113 | 776.83M |
| 223 | TRVI | Trevi Therapeutics, Inc. | 2.65B | 2.64% | 2,889,134 | - |
| 224 | TARS | Tarsus Pharmaceuticals, Inc. | 2.64B | -2.64% | 979,586 | 535.08M |
| 225 | ESTA | Establishment Labs Holdings Inc. | 2.57B | -1.09% | 540,949 | 229.58M |
| 226 | MBX | MBX Biosciences, Inc. | 2.56B | 2.94% | 1,177,676 | - |
| 227 | GRDN | Guardian Pharmacy Services, Inc. | 2.56B | -4.42% | 533,305 | 1.46B |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.55B | 0.98% | 2,456,145 | 3.37B |
| 229 | ABCL | AbCellera Biologics Inc. | 2.48B | 10.03% | 16,241,861 | 79.21M |
| 230 | NRIX | Nurix Therapeutics, Inc. | 2.47B | 4.15% | 2,525,437 | 71.78M |
| 231 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.43B | -3.92% | 6,533,629 | 885.72M |
| 232 | PHVS | Pharvaris N.V. | 2.43B | 2.06% | 725,357 | - |
| 233 | IMNM | Immunome, Inc. | 2.38B | 5.41% | 1,598,579 | 4.02M |
| 234 | AXGN | Axogen, Inc. | 2.38B | -0.47% | 1,147,980 | 238.11M |
| 235 | MLYS | Mineralys Therapeutics, Inc. | 2.37B | 0.75% | 1,606,600 | - |
| 236 | KOD | Kodiak Sciences Inc. | 2.36B | 5.01% | 941,184 | - |
| 237 | BFLY | Butterfly Network, Inc. | 2.33B | 0.22% | 12,967,030 | 102.92M |
| 238 | TMDX | TransMedics Group, Inc. | 2.33B | -1.68% | 1,250,118 | 635.89M |
| 239 | NTLA | Intellia Therapeutics, Inc. | 2.32B | -0.42% | 5,581,610 | 66.09M |
| 240 | KARD | Kardigan, Inc. | 2.31B | 9.75% | 1,376,051 | - |
| 241 | VCEL | Vericel Corporation | 2.30B | -2.51% | 772,104 | 292.09M |
| 242 | PBH | Prestige Consumer Healthcare Inc. | 2.28B | -2.79% | 835,611 | 1.09B |
| 243 | AGIO | Agios Pharmaceuticals, Inc. | 2.26B | 0.37% | 771,616 | 66.05M |
| 244 | PGNY | Progyny, Inc. | 2.26B | 1.23% | 1,279,329 | 1.29B |
| 245 | BHVN | Biohaven Ltd. | 2.25B | -5.56% | 3,497,718 | - |
| 246 | ASTH | Astrana Health, Inc. | 2.23B | 1.17% | 714,199 | 3.53B |
| 247 | PVLA | Palvella Therapeutics, Inc. | 2.22B | 4.47% | 324,116 | - |
| 248 | NKTR | Nektar Therapeutics | 2.21B | 2.73% | 1,209,614 | 55.63M |
| 249 | LMAT | LeMaitre Vascular, Inc. | 2.19B | 0.36% | 397,809 | 256.28M |
| 250 | GENB | Generate Biomedicines, Inc. | 2.17B | 2.67% | 1,706,585 | 30.30M |
| 251 | OCUL | Ocular Therapeutix, Inc. | 2.17B | 0.61% | 2,060,990 | 52.04M |
| 252 | XRAY | DENTSPLY SIRONA Inc. | 2.17B | -1.73% | 4,626,608 | 3.68B |
| 253 | AUPH | Aurinia Pharmaceuticals Inc. | 2.16B | -2.55% | 3,617,303 | 298.30M |
| 254 | TSHA | Taysha Gene Therapies, Inc. | 2.15B | 6.15% | 5,555,863 | 7.47M |
| 255 | SGRY | Surgery Partners, Inc. | 2.15B | 4.68% | 1,430,943 | 3.34B |
| 256 | PGEN | Precigen, Inc. | 2.11B | 1.02% | 6,286,643 | 31.60M |
| 257 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.08B | 5.12% | 2,423,817 | -665.00K |
| 258 | VRDN | Viridian Therapeutics, Inc. | 2.07B | 4.97% | 7,604,618 | 70.92M |
| 259 | ZLAB | Zai Lab Limited | 2.07B | 2.28% | 944,868 | 453.28M |
| 260 | WGS | GeneDx Holdings Corp. | 2.05B | -1.00% | 1,014,918 | 442.68M |
| 261 | SEM | Select Medical Holdings Corporation | 2.05B | 0.18% | 3,731,364 | 5.52B |
| 262 | HRMY | Harmony Biosciences Holdings, Inc. | 2.05B | -0.37% | 830,029 | 899.11M |
| 263 | UFPT | UFP Technologies, Inc. | 2.04B | 1.47% | 165,379 | 608.85M |
| 264 | CMPS | COMPASS Pathways plc | 2.03B | 1.69% | 3,601,557 | - |
| 265 | PLSE | Pulse Biosciences, Inc. | 2.02B | 2.78% | 466,616 | 751.00K |
| 266 | GLUE | Monte Rosa Therapeutics, Inc. | 2.02B | 7.22% | 1,840,327 | 42.95M |
| 267 | STOK | Stoke Therapeutics, Inc. | 2.02B | 1.22% | 652,144 | 32.08M |
| 268 | NEOG | Neogen Corporation | 1.98B | -5.01% | 2,725,259 | 870.56M |
| 269 | MD | Pediatrix Medical Group, Inc. | 1.98B | 0.04% | 776,574 | 1.93B |
| 270 | ATAI | AtaiBeckley Inc. | 1.97B | 1.32% | 10,553,862 | 3.49M |
| 271 | RXRX | Recursion Pharmaceuticals, Inc. | 1.96B | 4.83% | 22,932,659 | 66.41M |
| 272 | GHRS | GH Research PLC | 1.95B | 0.96% | 229,080 | - |
| 273 | NUVB | Nuvation Bio Inc. | 1.95B | -0.71% | 10,719,114 | 143.05M |
| 274 | SION | Sionna Therapeutics, Inc. | 1.94B | 1.87% | 306,936 | - |
| 275 | ADMA | ADMA Biologics, Inc. | 1.94B | -4.34% | 4,300,591 | 509.86M |
| 276 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 0.85% | 122,617 | 1.20B |
| 277 | RAPP | Rapport Therapeutics, Inc. | 1.93B | 0.82% | 435,858 | 20.00M |
| 278 | SNDX | Syndax Pharmaceuticals, Inc. | 1.93B | 2.21% | 4,704,817 | 217.17M |
| 279 | BCAX | Bicara Therapeutics Inc. | 1.93B | 9.19% | 1,568,083 | - |
| 280 | ALMR | Alamar Biosciences, Inc. | 1.92B | 4.12% | 469,299 | 87.16M |
| 281 | ABSI | Absci Corporation | 1.92B | 4.22% | 8,118,988 | 1.84M |
| 282 | AGL | agilon health, inc. | 1.92B | -3.44% | 440,743 | 5.82B |
| 283 | ANAB | AnaptysBio, Inc. | 1.92B | 4.47% | 778,448 | 232.39M |
| 284 | TYRA | Tyra Biosciences, Inc. | 1.91B | 0.78% | 632,541 | - |
| 285 | AVAH | Aveanna Healthcare Holdings Inc. | 1.89B | - | 1,660,139 | 2.52B |
| 286 | IOVA | Iovance Biotherapeutics, Inc. | 1.88B | -0.94% | 10,654,770 | 285.61M |
| 287 | OMCL | Omnicell, Inc. | 1.86B | 1.97% | 548,956 | 1.23B |
| 288 | NEO | NeoGenomics, Inc. | 1.86B | 0.56% | 2,482,696 | 745.97M |
| 289 | SNDA | Sonida Senior Living, Inc. | 1.85B | 1.64% | 484,971 | 367.34M |
| 290 | HCM | HUTCHMED (China) Limited | 1.82B | 5.31% | 40,337 | 548.51M |
| 291 | BHC | Bausch Health Companies Inc. | 1.81B | 1.89% | 4,335,140 | 10.53B |
| 292 | NBTX | Nanobiotix S.A. | 1.80B | -0.08% | 109,630 | 38.27M |
| 293 | SRPT | Sarepta Therapeutics, Inc. | 1.80B | 1.01% | 3,803,841 | 2.18B |
| 294 | NVCR | NovoCure Limited | 1.79B | 0.32% | 1,060,888 | 674.41M |
| 295 | ADUS | Addus HomeCare Corporation | 1.79B | 1.13% | 324,753 | 1.45B |
| 296 | ANIP | ANI Pharmaceuticals, Inc. | 1.78B | -0.46% | 315,389 | 923.71M |
| 297 | TRLV | Trulieve Cannabis Corp. | 1.78B | 2.78% | 1,035,346 | 1.17B |
| 298 | ZYME | Zymeworks Inc. | 1.76B | -0.12% | 1,056,162 | 81.26M |
| 299 | URGN | UroGen Pharma Ltd. | 1.76B | 4.43% | 600,248 | 140.49M |
| 300 | VIR | Vir Biotechnology, Inc. | 1.75B | 3.49% | 1,935,344 | 65.50M |
| 301 | MESO | Mesoblast Limited | 1.74B | 3.18% | 150,825 | 65.38M |
| 302 | COAG | Hemab Therapeutics Holdings, Inc. | 1.72B | 13.47% | 361,749 | - |
| 303 | INVA | Innoviva, Inc. | 1.71B | -1.82% | 878,668 | 420.69M |
| 304 | HCSG | Healthcare Services Group, Inc. | 1.68B | 0.78% | 482,135 | 1.85B |
| 305 | AKTS | Aktis Oncology, Inc. | 1.66B | 2.28% | 539,411 | 8.28M |
| 306 | FTRE | Fortrea Holdings Inc. | 1.66B | -0.74% | 1,208,871 | 2.71B |
| 307 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.65B | 2.73% | 3,061,598 | 204.73M |
| 308 | MLTX | MoonLake Immunotherapeutics | 1.64B | 0.05% | 1,313,873 | - |
| 309 | ZBIO | Zenas BioPharma, Inc. | 1.61B | -1.24% | 1,728,456 | 10.00M |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.61B | 2.00% | 772,343 | 20.00M |
| 311 | AVBP | ArriVent BioPharma, Inc. | 1.60B | 1.09% | 485,925 | - |
| 312 | AAPG | Ascentage Pharma Group International | 1.58B | 5.25% | 10,878 | 82.08M |
| 313 | INNV | InnovAge Holding Corp. | 1.58B | 7.60% | 835,911 | 949.17M |
| 314 | TDOC | Teladoc Health, Inc. | 1.57B | 3.58% | 6,384,589 | 2.51B |
| 315 | SEPN | Septerna, Inc. | 1.57B | -6.94% | 1,432,556 | 72.26M |
| 316 | MPLT | MapLight Therapeutics, Inc. | 1.56B | 3.06% | 362,022 | - |
| 317 | IMCR | Immunocore Holdings plc | 1.55B | -1.49% | 501,567 | 412.81M |
| 318 | NVAX | Novavax, Inc. | 1.54B | 5.41% | 4,039,731 | 596.34M |
| 319 | HROW | Harrow, Inc. | 1.53B | -2.19% | 482,787 | 268.68M |
| 320 | SVRA | Savara Inc. | 1.53B | 2.20% | 1,547,383 | - |
| 321 | CDNA | CareDx, Inc. | 1.51B | 1.60% | 497,978 | 412.82M |
| 322 | DMRA | Damora Therapeutics, Inc. | 1.49B | -4.53% | 520,248 | - |
| 323 | KMTS | Kestra Medical Technologies, Ltd. | 1.48B | -4.09% | 731,307 | 83.72M |
| 324 | ATEC | Alphatec Holdings, Inc. | 1.46B | 2.15% | 4,067,403 | 787.08M |
| 325 | STAA | STAAR Surgical Company | 1.46B | 0.14% | 953,586 | 290.38M |
| 326 | IART | Integra LifeSciences Holdings Corporation | 1.46B | -0.11% | 987,428 | 1.64B |
| 327 | ATRC | AtriCure, Inc. | 1.45B | -4.90% | 1,972,675 | 552.16M |
| 328 | PSNL | Personalis, Inc. | 1.44B | 5.61% | 3,775,572 | 64.52M |
| 329 | ARDT | Ardent Health, Inc. | 1.42B | 2.06% | 527,811 | 6.43B |
| 330 | INBX | Inhibrx Biosciences, Inc. | 1.40B | 0.73% | 410,742 | 1.30M |
| 331 | PRGO | Perrigo Company plc | 1.39B | 1.01% | 4,356,411 | 4.18B |
| 332 | BLFS | BioLife Solutions, Inc. | 1.38B | -1.29% | 3,427,200 | 101.66M |
| 333 | CAPR | Capricor Therapeutics, Inc. | 1.38B | -9.98% | 3,243,273 | 11.13M |
| 334 | AVLN | Avalyn Pharma Inc. | 1.37B | 1.37% | 348,670 | - |
| 335 | AHCO | AdaptHealth Corp. | 1.36B | -0.78% | 1,888,490 | 3.29B |
| 336 | XERS | Xeris Biopharma Holdings, Inc. | 1.34B | 0.65% | 2,575,685 | 314.85M |
| 337 | JBIO | Jade Biosciences, Inc. | 1.31B | 0.64% | 1,122,368 | - |
| 338 | MNKD | MannKind Corporation | 1.31B | 2.42% | 3,420,157 | 360.78M |
| 339 | IMTX | Immatics N.V. | 1.31B | 0.42% | 331,278 | 43.00M |
| 340 | SDGR | Schrödinger, Inc. | 1.30B | 3.14% | 1,957,098 | 254.91M |
| 341 | INSP | Inspire Medical Systems, Inc. | 1.29B | -1.73% | 717,059 | 915.25M |
| 342 | ARDX | Ardelyx, Inc. | 1.29B | -5.77% | 8,988,538 | 427.68M |
| 343 | PAHC | Phibro Animal Health Corporation | 1.29B | 0.38% | 389,811 | 1.50B |
| 344 | OMDA | Omada Health, Inc. | 1.29B | 3.73% | 1,771,686 | 283.30M |
| 345 | PRCT | PROCEPT BioRobotics Corporation | 1.29B | 0.09% | 1,126,608 | 322.02M |
| 346 | ENOV | Enovis Corporation | 1.27B | -3.04% | 1,403,503 | 2.28B |
| 347 | PNTG | The Pennant Group, Inc. | 1.26B | 1.20% | 317,243 | 1.02B |
| 348 | ALVO | Alvotech | 1.26B | 1.09% | 690,356 | 562.04M |
| 349 | AMN | AMN Healthcare Services, Inc. | 1.26B | -1.16% | 682,337 | 3.42B |
| 350 | QDEL | QuidelOrtho Corporation | 1.24B | 32.20% | 6,603,408 | 2.66B |
| 351 | AHG | Akso Health Group | 1.24B | -4.61% | 17,203 | 14.84M |
| 352 | CRVS | Corvus Pharmaceuticals, Inc. | 1.22B | 7.34% | 1,495,757 | - |
| 353 | SPTX | Seaport Therapeutics, Inc. | 1.21B | 5.23% | 232,267 | - |
| 354 | IRMD | IRADIMED CORPORATION | 1.20B | 0.12% | 104,749 | 86.28M |
| 355 | EYPT | EyePoint, Inc. | 1.18B | 3.29% | 1,579,209 | 7.61M |
| 356 | AZTA | Azenta, Inc. | 1.18B | 0.04% | 513,705 | 596.48M |
| 357 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.17B | 3.53% | 4,632,035 | 69.64M |
| 358 | AVNS | Avanos Medical, Inc. | 1.17B | -0.08% | 631,715 | 715.90M |
| 359 | COLL | Collegium Pharmaceutical, Inc. | 1.17B | -1.67% | 510,631 | 796.33M |
| 360 | MGTX | MeiraGTx Holdings plc | 1.16B | 3.55% | 682,557 | 79.76M |
| 361 | XNCR | Xencor, Inc. | 1.16B | 3.65% | 749,202 | 97.36M |
| 362 | NUTX | Nutex Health Inc. | 1.15B | 0.72% | 197,400 | 879.95M |
| 363 | OPK | OPKO Health, Inc. | 1.14B | -1.31% | 5,806,280 | 581.12M |
| 364 | CGEM | Cullinan Therapeutics, Inc. | 1.13B | 0.11% | 989,958 | - |
| 365 | BIOA | BioAge Labs, Inc. | 1.11B | 5.01% | 768,425 | 10.32M |
| 366 | LMRI | Lumexa Imaging Holdings, Inc. | 1.10B | -5.12% | 811,738 | 1.03B |
| 367 | WVE | Wave Life Sciences Ltd. | 1.09B | -2.57% | 2,737,452 | 71.80M |
| 368 | AORT | Artivion, Inc. | 1.09B | -5.17% | 1,017,308 | 458.69M |
| 369 | TNDM | Tandem Diabetes Care, Inc. | 1.08B | -2.52% | 1,467,176 | 1.03B |
| 370 | OLMA | Olema Pharmaceuticals, Inc. | 1.07B | 7.11% | 1,442,880 | - |
| 371 | CRON | Cronos Group Inc. | 1.06B | 1.42% | 904,430 | 159.54M |
| 372 | ORIC | ORIC Pharmaceuticals, Inc. | 1.05B | 6.56% | 1,123,898 | - |
| 373 | USPH | U.S. Physical Therapy, Inc. | 1.05B | 0.06% | 263,817 | 787.69M |
| 374 | CNMD | CONMED Corporation | 1.04B | -4.28% | 727,550 | 1.37B |
| 375 | SANA | Sana Biotechnology, Inc. | 1.03B | 0.88% | 2,523,349 | - |
| 376 | AVTX | Avalo Therapeutics, Inc. | 1.01B | 5.99% | 1,580,604 | 59.00K |
| 377 | DRTS | Alpha Tau Medical Ltd. | 1.01B | 3.12% | 877,715 | - |
| 378 | EVO | Evotec SE | 1.01B | 1.82% | 55,550 | 859.03M |
| 379 | VOR | Vor Biopharma Inc. | 1.01B | 15.53% | 2,818,541 | - |
| 380 | ETON | Eton Pharmaceuticals, Inc. | 1.01B | 2.89% | 667,144 | 86.93M |
| 381 | CERT | Certara, Inc. | 989.39M | 8.90% | 4,879,702 | 419.75M |
| 382 | PCRX | Pacira BioSciences, Inc. | 987.24M | -0.59% | 392,252 | 734.86M |
| 383 | ANRO | Alto Neuroscience, Inc. | 985.09M | 3.81% | 644,896 | - |
| 384 | KURA | Kura Oncology, Inc. | 973.85M | 0.64% | 1,164,715 | 71.64M |
| 385 | DBVT | DBV Technologies S.A. | 967.91M | -0.06% | 507,589 | 5.74M |
| 386 | GDRX | GoodRx Holdings, Inc. | 965.22M | 1.79% | 1,239,713 | 787.89M |
| 387 | AVR | Anteris Technologies Global Corp. | 952.01M | 0.93% | 1,549,584 | 1.85M |
| 388 | PHAR | Pharming Group N.V. | 947.75M | 0.37% | 8,298 | 369.49M |
| 389 | REPL | Replimune Group, Inc. | 940.19M | -3.70% | 3,737,247 | - |
| 390 | LBRX | LB Pharmaceuticals Inc | 936.01M | 2.26% | 367,465 | - |
| 391 | JANX | Janux Therapeutics, Inc. | 934.59M | 2.58% | 1,191,682 | 13.73M |
| 392 | INMD | InMode Ltd. | 933.91M | 0.75% | 591,778 | 374.64M |
| 393 | SLDB | Solid Biosciences Inc. | 932.32M | 1.94% | 1,704,696 | - |
| 394 | ABUS | Arbutus Biopharma Corporation | 924.48M | 2.18% | 2,503,964 | 191.45M |
| 395 | AMPH | Amphastar Pharmaceuticals, Inc. | 913.16M | -4.50% | 727,053 | 720.53M |
| 396 | ANNX | Annexon, Inc. | 912.60M | 1.64% | 8,568,148 | - |
| 397 | ODTX | Odyssey Therapeutics, Inc. | 904.42M | 4.26% | 388,824 | 1.06M |
| 398 | DSGN | Design Therapeutics, Inc. | 889.39M | 6.67% | 1,495,199 | - |
| 399 | TBPH | Theravance Biopharma, Inc. | 879.49M | -3.23% | 3,127,585 | 109.78M |
| 400 | AGMB | AgomAb Therapeutics NV | 877.60M | 29.04% | 200,152 | - |
| 401 | TALK | Talkspace, Inc. | 871.07M | -0.38% | 2,063,342 | 238.37M |
| 402 | PHAT | Phathom Pharmaceuticals, Inc. | 863.41M | 1.40% | 1,122,882 | 204.89M |
| 403 | SPRY | ARS Pharmaceuticals, Inc. | 850.04M | 0.23% | 1,407,642 | 98.99M |
| 404 | GERN | Geron Corporation | 833.98M | -1.52% | 14,561,547 | 196.12M |
| 405 | ZVRA | Zevra Therapeutics, Inc. | 828.20M | 3.62% | 1,538,957 | 122.29M |
| 406 | BVS | Bioventus Inc. | 816.97M | - | 582,718 | 576.30M |
| 407 | CTMX | CytomX Therapeutics, Inc. | 814.21M | 10.00% | 6,959,556 | 35.54M |
| 408 | ESPR | Esperion Therapeutics, Inc. | 810.91M | -0.63% | 5,734,011 | 418.24M |
| 409 | GMRS | GMR Solutions Inc. | 795.05M | 1.31% | 812,688 | 5.83B |
| 410 | HSTM | HealthStream, Inc. | 792.61M | 1.50% | 286,886 | 311.78M |
| 411 | OCS | Oculis Holding AG | 790.48M | 9.08% | 661,660 | 1.40M |
| 412 | ALLO | Allogene Therapeutics, Inc. | 766.24M | 4.23% | 14,663,951 | 22.00K |
| 413 | CLYM | Climb Bio, Inc. | 765.00M | 2.14% | 1,161,456 | - |
| 414 | IVA | Inventiva S.A. | 761.81M | 4.11% | 1,190,055 | 7.94M |
| 415 | CADL | Candel Therapeutics, Inc. | 759.08M | 5.82% | 1,488,455 | - |
| 416 | AURA | Aura Biosciences, Inc. | 758.86M | -1.71% | 382,988 | - |
| 417 | BBNX | Beta Bionics, Inc. | 757.55M | 1.07% | 715,267 | 110.24M |
| 418 | CBLL | CeriBell, Inc. | 757.34M | -0.10% | 235,498 | 95.07M |
| 419 | NVCT | Nuvectis Pharma, Inc. | 756.77M | 4.93% | 518,797 | - |
| 420 | SIBN | SI-BONE, Inc. | 748.62M | -2.51% | 487,295 | 206.22M |
| 421 | IMMX | Immix Biopharma, Inc. | 746.78M | 5.11% | 1,855,849 | - |
| 422 | CSTL | Castle Biosciences, Inc. | 737.62M | 0.08% | 324,260 | 339.92M |
| 423 | RLMD | Relmada Therapeutics, Inc. | 732.13M | 4.33% | 2,311,664 | - |
| 424 | SGP | SpyGlass Pharma, Inc. | 723.83M | 2.22% | 105,001 | - |
| 425 | RIGL | Rigel Pharmaceuticals, Inc. | 722.32M | 0.90% | 283,732 | 299.77M |
| 426 | OMER | Omeros Corporation | 717.24M | 14.30% | 2,743,415 | 9.89M |
| 427 | IRWD | Ironwood Pharmaceuticals, Inc. | 707.84M | 4.12% | 3,501,855 | 361.51M |
| 428 | SSII | SS Innovations International, Inc. | 706.46M | 2.99% | 22,052 | 48.47M |
| 429 | ACRS | Aclaris Therapeutics, Inc. | 701.11M | 0.40% | 1,840,968 | 8.37M |
| 430 | TENX | Tenax Therapeutics, Inc. | 689.74M | 0.45% | 648,504 | - |
| 431 | EIKN | Eikon Therapeutics, Inc. | 689.73M | 11.27% | 459,916 | - |
| 432 | TCMD | Tactile Systems Technology, Inc. | 682.78M | -0.03% | 246,370 | 343.52M |
| 433 | FDMT | 4D Molecular Therapeutics, Inc. | 673.32M | 11.03% | 1,522,859 | 88.24M |
| 434 | PRME | Prime Medicine, Inc. | 671.90M | 8.45% | 5,294,359 | 4.03M |
| 435 | DRUG | Bright Minds Biosciences Inc. | 671.06M | 5.15% | 335,438 | - |
| 436 | DNA | Ginkgo Bioworks Holdings, Inc. | 666.96M | -0.39% | 1,317,243 | 151.40M |
| 437 | EVH | Evolent Health, Inc. | 649.02M | 4.72% | 2,948,979 | 1.89B |
| 438 | ACHV | Achieve Life Sciences, Inc. | 639.57M | 3.49% | 2,176,231 | - |
| 439 | PHR | Phreesia, Inc. | 636.04M | 2.18% | 1,330,684 | 495.59M |
| 440 | MNPR | Monopar Therapeutics Inc. | 633.44M | 7.85% | 119,867 | - |
| 441 | TECX | Tectonic Therapeutic, Inc. | 624.38M | 3.31% | 256,801 | - |
| 442 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 613.62M | 3.51% | 235,826 | - |
| 443 | RGNX | REGENXBIO Inc. | 611.58M | 12.88% | 2,544,012 | 87.82M |
| 444 | CRMD | CorMedix Inc. | 599.37M | -2.68% | 1,283,489 | 400.05M |
| 445 | CERS | Cerus Corporation | 599.10M | 2.40% | 2,341,268 | 216.56M |
| 446 | FTH | Faeth Therapeutics, Inc. | 598.58M | 1.53% | 66,778 | - |
| 447 | CBIO | Crescent Biopharma, Inc. | 598.12M | -3.02% | 430,465 | 11.88M |
| 448 | NNNN | Anbio Biotechnology | 594.73M | -6.74% | 34,612 | 8.65M |
| 449 | TRAX | First Tracks Biotherapeutics, Inc. | 593.52M | 5.80% | 331,108 | - |
| 450 | BWAY | BrainsWay Ltd. | 589.85M | 4.77% | 114,128 | 56.22M |
| 451 | GYRE | Gyre Therapeutics, Inc. | 589.35M | 2.94% | 79,749 | 117.05M |
| 452 | FLGT | Fulgent Genetics, Inc. | 583.06M | 2.86% | 294,585 | 320.35M |
| 453 | CLPT | ClearPoint Neuro, Inc. | 582.70M | 5.14% | 878,094 | 40.61M |
| 454 | MDXG | MiMedx Group, Inc. | 582.38M | -0.51% | 1,299,925 | 389.42M |
| 455 | CTEV | Claritev Corporation | 576.56M | 2.02% | 145,965 | 978.76M |
| 456 | ALT | Altimmune, Inc. | 571.75M | 4.26% | 3,638,518 | 36.00K |
| 457 | PROK | ProKidney Corp. | 570.89M | 3.28% | 1,437,836 | 889.00K |
| 458 | OCGN | Ocugen, Inc. | 565.33M | 11.33% | 14,239,023 | 4.47M |
| 459 | NPCE | NeuroPace, Inc. | 563.57M | 0.36% | 161,368 | 99.53M |
| 460 | CTNM | Contineum Therapeutics, Inc. | 560.80M | 5.63% | 447,552 | - |
| 461 | CTKB | Cytek Biosciences, Inc. | 560.48M | -3.13% | 1,147,718 | 204.17M |
| 462 | TOI | The Oncology Institute, Inc. | 559.90M | 3.90% | 2,825,363 | 545.76M |
| 463 | STRO | Sutro Biopharma, Inc. | 552.62M | 9.27% | 465,218 | 99.61M |
| 464 | MYGN | Myriad Genetics, Inc. | 552.52M | -0.51% | 1,928,736 | 829.00M |
| 465 | ANGO | AngioDynamics, Inc. | 550.20M | -1.49% | 340,914 | 313.73M |
| 466 | TLRY | Tilray Brands, Inc. | 549.89M | -0.65% | 3,356,201 | 858.28M |
| 467 | SLBT | SL Science Holding Limited | 549.53M | -9.33% | 221,057 | - |
| 468 | EVMN | Evommune, Inc. | 542.08M | -40.23% | 10,586,547 | 10.00M |
| 469 | PACB | Pacific Biosciences of California, Inc. | 537.34M | 4.85% | 8,339,317 | 160.03M |
| 470 | ARVN | Arvinas, Inc. | 534.88M | 3.62% | 954,912 | 89.40M |
| 471 | ZURA | Zura Bio Limited | 534.84M | 5.23% | 2,454,722 | - |
| 472 | ASMB | Assembly Biosciences, Inc. | 534.27M | 0.82% | 236,137 | 71.10M |
| 473 | KYTX | Kyverna Therapeutics, Inc. | 533.78M | 4.03% | 1,389,630 | - |
| 474 | RZLT | Rezolute, Inc. | 532.78M | 1.19% | 1,753,798 | - |
| 475 | XOMA | XOMA Royalty Corporation | 528.60M | - | 368,062 | 48.56M |
| 476 | STTK | Shattuck Labs, Inc. | 525.26M | 6.37% | 2,043,235 | 1.00M |
| 477 | PRTA | Prothena Corporation plc | 521.96M | -0.50% | 420,010 | 57.94M |
| 478 | AQST | Aquestive Therapeutics, Inc. | 521.87M | -5.24% | 3,292,933 | 50.27M |
| 479 | FBRX | Forte Biosciences, Inc. | 520.97M | 1.38% | 474,506 | - |
| 480 | KIDS | OrthoPediatrics Corp. | 515.75M | -1.08% | 183,123 | 243.30M |
| 481 | NGNE | Neurogene Inc. | 510.09M | 0.78% | 544,568 | 925.00K |
| 482 | SLN | Silence Therapeutics plc | 509.65M | 6.41% | 1,151,129 | 839.00K |
| 483 | OVID | Ovid Therapeutics Inc. | 507.66M | 6.67% | 1,552,938 | 7.12M |
| 484 | CABA | Cabaletta Bio, Inc. | 507.10M | 2.30% | 5,544,072 | - |
| 485 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 486 | SOPH | SOPHiA GENETICS SA | 501.69M | 4.17% | 317,523 | 81.18M |
| 487 | EDIT | Editas Medicine, Inc. | 491.08M | 12.28% | 3,038,295 | 38.69M |
| 488 | PRLD | Prelude Therapeutics Incorporated | 488.95M | 12.56% | 477,944 | 16.72M |
| 489 | WEAV | Weave Communications, Inc. | 487.74M | 3.55% | 1,341,047 | 248.72M |
| 490 | NRC | NRC Health | 487.69M | 3.99% | 78,763 | 138.64M |
| 491 | SGMT | Sagimet Biosciences Inc. | 481.05M | 10.34% | 1,353,263 | - |
| 492 | CCCC | C4 Therapeutics, Inc. | 480.97M | 2.11% | 3,114,979 | 34.86M |
| 493 | VALN | Valneva SE | 479.75M | -0.39% | 36,780 | 180.25M |
| 494 | MOBI | Mobia Medical, Inc. | 478.12M | -1.71% | 157,975 | 38.45M |
| 495 | EOLS | Evolus, Inc. | 469.54M | - | 669,566 | 301.79M |
| 496 | ARTV | Artiva Biotherapeutics, Inc. | 465.47M | -0.42% | 447,214 | 251.00K |
| 497 | CYH | Community Health Systems, Inc. | 459.19M | 3.35% | 1,067,127 | 12.29B |
| 498 | ANL | Adlai Nortye Ltd. | 456.40M | 14.10% | 203,314 | 5.00M |
| 499 | VTVT | vTv Therapeutics Inc. | 450.09M | 2.31% | 79,904 | 36.84M |
| 500 | SRTA | Strata Critical Medical, Inc. | 448.21M | -2.26% | 1,303,256 | 228.58M |